TAMSULOSIN VERSUS ALFUZOSIN IN THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS

Not Applicable

Not yet recruiting

Conditions: Benign prostatic hyperplasia withlower urinary tract symptoms,

Registration Number: CTRI/2020/06/025806

Lead Sponsor: ARMED FORCES MEDICAL COLLEGE

Brief Summary: To compare the efficacy of Tamsulosin and Alfuzosin in the treatment of Lower Urinary tract symptoms in a case of Benign Prostate Hypertrophy in a tertiary care centre, all male patients of BPH between the ages of 40 to 80 years are evaluated by taking detailed history, clinical examination, USG KUBP & IPSS scrore. Patients would be randomised into two groups by a computer generated random table. Patients in one group would be given Tab Tamsulosin and other group would be given Tab Alfuzosin. Patients would be reviewed after 06 months and IPSS would be retaken. Pre and post treatment scores would be compared within the group and post treatment groups would be compared between the groups.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: Male

Target Recruitment: 100

Inclusion Criteria

presenting with lower urinary tract symptoms.

Exclusion Criteria

Past history of Prostate surgery, urethral stricture, bladder neck stenosis, vesical calculus, urethral or bladder diverticulum, neurogenic bladder, prostate or bladder cancer.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To study improvement in International Prostate symptom score (IPSS)	24 months

Secondary Outcome Measures

Name	Time	Method
To compare the efficacy of each drug individually	24 months

Trial Locations

Locations (1): Armed Forces Medical College
🇮🇳
Pune, MAHARASHTRA, India
Armed Forces Medical College
🇮🇳Pune, MAHARASHTRA, India
Akil Anand
Principal investigator
9160408457
a7anand@gmail.com